-

Hanger Announces Date of 2021 First Quarter Earnings Release and Conference Call

AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the first quarter ended March 31, 2021 after the stock market closes on Wednesday, May 5, 2021.

Hanger's management team will host a conference call with the financial community to discuss the financial results the following morning on Thursday, May 6 at 8:30 a.m. Eastern time.

A live webcast, replay of the call and earnings release, will be available on the Company's Investor Relations website: investor.hanger.com/financial-reporting.

For members of the financial community participating in the conference call: dial 844-750-4896, or 412-317-5292 outside the U.S. and Canada, and ask to be joined into the Hanger, Inc. call.

About Hanger, Inc. – Headquartered in Austin, Texas, Hanger, Inc. (NYSE: HNGR) provides comprehensive, outcomes-based orthotic and prosthetic (O&P) services through its Patient Care segment, with approximately 800 Hanger Clinic locations nationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. Recognized by Forbes as one of America’s Best Employers for 2021, and rooted in 160 years of clinical excellence and innovation, Hanger is a purpose-driven company with a vision to lead the O&P markets by providing superior patient care, outcomes, services and value, aimed at empowering human potential. For more information on Hanger, visit investor.hanger.com.

This press release contains statements that are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include information concerning our liquidity and our possible or assumed future results of operations, including descriptions of our business strategies. These statements often include words such as “believe,” “expect,” “project,” “potential,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may,” “would,” “should,” “could,” “forecasts” or similar words. These statements are based on certain assumptions that we have made in light of our experience in the industry as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. We believe these assumptions are reasonable, but you should understand that these statements are not guarantees of performance or results, and our actual results could differ materially from those expressed in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent releases or reports. These statements involve risks, estimates, assumptions, and uncertainties that could cause actual results to differ materially from those expressed in these statements and elsewhere in this release. These uncertainties include, but are not limited to, the financial and business impacts of COVID-19 on our operations and the operations of our customers, suppliers, governmental and private payers and others in the healthcare industry and beyond; federal laws governing the health care industry; governmental policies affecting O&P operations, including with respect to reimbursement; failure to successfully implement a new enterprise resource planning system or other disruptions to information technology systems; the inability to successfully execute our acquisition strategy, including integration of recently acquired O&P clinics into our existing business; changes in the demand for our O&P products and services, including additional competition in the O&P services market; disruptions to our supply chain; our ability to enter into and derive benefits from managed-care contracts; our ability to successfully attract and retain qualified O&P clinicians; and other risks and uncertainties generally affecting the health care industry. For additional information and risk factors that could affect the Company, see its Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission. The information contained in this press release is made only as of the date hereof, even if subsequently made available by the Company on its website or otherwise.

Contacts

Investor Relations Contact:
Seth Frank, Vice President, Treasury and Investor Relations
Hanger, Inc.
512-777-3573
sfrank@hanger.com

Hanger, Inc.

NYSE:HNGR

Release Summary
Q1 2021 Earnings Date Announcement
Release Versions
$Cashtags

Contacts

Investor Relations Contact:
Seth Frank, Vice President, Treasury and Investor Relations
Hanger, Inc.
512-777-3573
sfrank@hanger.com

More News From Hanger, Inc.

Hanger Ventures Announces Inaugural Investment

AUSTIN, Texas--(BUSINESS WIRE)--Hanger Ventures, a Hanger, Inc. business whose primary objective is to advance orthotics and prosthetics innovation and improve patient outcomes, today announced its debut investment in Bionic Power, a Canadian-based firm. A developer of active lower body smart orthotic devices that enhance personal mobility, Bionic Power is raising Series A Round funding, with Hanger Ventures committing as the lead investor. “We are thrilled to make our inaugural investment in B...

Hanger Launches Ventures Subsidiary to Support Orthotics and Prosthetics Entrepreneurs and Small Businesses

AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today the launch of Hanger Ventures, a subsidiary designed to focus on accelerating innovation, developing technology, and improving patient outcomes worldwide. Using robust clinical expertise and scale, Hanger Ventures will invest in entrepreneurs and small businesses, helping to bring innovative O&P healthcare solutions to the market. “Hanger...

Hanger Announces Pete Stoy as CEO

AUSTIN, Texas--(BUSINESS WIRE)--Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Pete Stoy, formerly the company’s President and Chief Operating Officer, has assumed the role of Hanger’s Chief Executive Officer (CEO), effective immediately. Stoy will also serve on Hanger’s Board of Directors. Stoy’s appointment was announced in January as part of a multi-year succession plan, and follows the retirement of Vinit Asar who h...
Back to Newsroom